Biomedical Data Science
Third-party funded projects
- EBStatMax: State-of-the-art statistical design and analysis for maximal success with minimal patient burden in Epidermolysis bullosa trials. European Joint Programme on Rare Diseases, Lead: Univ.-Prof. Johann Bauer, Department of Dermatology und Allergology, University Hospital Salzburg, Project partner: Universität Leuven / Hasselt (BEL), Universität Uppsala (SWE), January 2021 – June 2023
- Application potential of innovative methodological approaches for extracting medical research knowledge and analysis with artificial intelligence. Zentrales Innovationsprogramm Mittelstand des BM für Wirtschaft und Klimaschutz Deutschland, Lead: medicalvalues, October 2021 – January 2022
- AIDA-PATH: AI-based identification of "long COVID"-related diagnostic pathways. Innovation Express Call 2021, Lead: IDA Lab Salzburg/Paris Lodron University Salzburg (Christian Borgelt, Simon Hirländer), Project partner: industry partner medicalvalues (Karlsruhe, D), Center for Cognitive Neuroscience (Paris-Lodron-Universität Salzburg, Univ. Prof. Florian Hutzler), November 2021 – October 2024
- Characterization of imaging abnormalities and determining of their prognostic value in patients with status epilepticus. FWF, Lead: PD Dr. Giorgi Kuchukhidze, Department of Neurology, Christian-Doppler-Klinik, University Hospital Salzburg, Start January 2022 – July 2025
- iSTORE: Innovative statistical approaches to improve outcome in rare epilepsies: A model for rare and ultra-rare diseases, consortium with partners in Paris, Bochum, Aachen, Leuven (academia) und Basel (Novartis), April 2022 – June 024
- PEBLES: Cooperation with Epidermolyis Bullosa working groups in London for EB Registry (Theme "natural historystudies"), November 2023 - present
- servEB: Global Data and Patient Management for Rare Genetic Skin Diseases, in collaboration with EB House Austria (SALK), WISS 2025, January 2024 – Dezember 2025